- Home
- ANGO
ANGO
AngioDynamics Inc.
as 01-21-2025 4:00pm EST
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
| Founded: | 1988 | Country: | United States |
| Employees: | N/A | City: | LATHAM |
| Market Cap: | 279.1M | IPO Year: | 2004 |
| Target Price: | $13.00 | AVG Volume (30 days): | 849.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.55 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.26 - $13.13 | Next Earning Date: | 01-08-2025 |
| Revenue: | $286,498,000 | Revenue Growth: | -13.06% |
| Revenue Growth (this year): | -4.73% | Revenue Growth (next year): | 7.69% |
Latest AngioDynamics Inc. News
ANGO Breaking Stock News: Dive into ANGO Ticker-Specific Updates for Smart Investing
Business Wire
9 days ago
AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI
Zacks
13 days ago
AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines
TipRanks
13 days ago
AngioDynamics Reports Growth and Advances NanoKnife System
GuruFocus.com
13 days ago
AngioDynamics Inc (ANGO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Thomson Reuters StreetEvents
13 days ago
Q2 2025 AngioDynamics Inc Earnings Call
MT Newswires
14 days ago
AngioDynamics Shares Jump Following Fiscal Q2 Results
Zacks
14 days ago
AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates
Associated Press Finance
14 days ago
AngioDynamics: Fiscal Q2 Earnings Snapshot
Compare ANGO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ANGO AngioDynamics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.